Impact of Modified TICI 3 versus Modified TICI 2b Reperfusion Score to Predict Good Outcome following Endovascular Therapy

BACKGROUND AND PURPOSE: The TICI score is widely used to evaluate cerebral perfusion before and after the endovascular treatment of stroke. Recent studies showing the effectiveness and safety of mechanical thrombectomy combine modified TICI 2b and modified TICI 3 to assess the technical success of endovascular treatment. The purpose of this study was to determine how much clinical outcomes differ between patients achieving modified TICI 2b and modified TICI 3 reperfusion. MATERIALS AND METHODS: We analyzed 222 consecutive patients with acute large intracranial artery occlusion of the anterior circulation having achieved modified TICI 2b or modified TICI 3 reperfusion after thrombectomy. The primary end point was the rate of favorable outcome defined as the achievement of a modified Rankin Scale score of 0–2 at 3 months. RESULTS: Patients with modified TICI 3 more often had favorable collateral circulation and atherosclerosis etiology, with a shorter time from onset to reperfusion than patients with modified TICI 2b (all P < .05). The number of total passes to achieve reperfusion was higher in the modified TICI 2b group (median, 2; interquartile range, 1–3, 1–9) versus (median, 1; interquartile range, 1–2, 1–8) in the modified TICI 3 group (P = .0002). Favorable outcome was reached more often for patients with modified TICI 3 than for those with modified TICI 2b (71.7% versus 50.5%, P = .001), with a similar difference when considering excellent outcome. In addition, patients with modified TICI 3 had a lower intracerebral hemorrhage rate (23.0% versus 45.0%, P < .001). CONCLUSIONS: Patients with modified TICI 3 reperfusion have better functional outcomes than those with modified TICI 2b. Given the improving reperfusion rates obtained with thrombectomy devices, future thrombectomy trials should consider modified TICI 2b and modified TICI 3 status separately.

[1]  Lena Osterhagen,et al.  Multiple Imputation For Nonresponse In Surveys , 2016 .

[2]  J. Broderick,et al.  Interventional Management of Stroke (IMS III) Trial , 2011 .

[3]  J. Broderick,et al.  Revascularization Results in the Interventional Management of Stroke II Trial , 2008, American Journal of Neuroradiology.

[4]  R. Gonzalez,et al.  Time and Diffusion Lesion Size in Major Anterior Circulation Ischemic Strokes , 2014, Stroke.

[5]  J. Mocco,et al.  ADAPT FAST study: a direct aspiration first pass technique for acute stroke thrombectomy , 2014, Journal of NeuroInterventional Surgery.

[6]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[7]  M. Hennerici,et al.  Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. , 1998, Archives of neurology.

[8]  V. Costes,et al.  High CD3+ Cells in Intracranial Thrombi Represent a Biomarker of Atherothrombotic Stroke , 2016, PloS one.

[9]  Joseph P. Broderick,et al.  Methodology of the Interventional Management of Stroke III Trial , 2008, International journal of stroke : official journal of the International Stroke Society.

[10]  C. Zimmer,et al.  Time to redefine success? TICI 3 versus TICI 2b recanalization in middle cerebral artery occlusion treated with thrombectomy , 2016, Journal of NeuroInterventional Surgery.

[11]  D. Kallmes,et al.  What Is Meant by “TICI”? , 2013, American Journal of Neuroradiology.

[12]  K. Major,et al.  The capillary index score: rethinking the acute ischemic stroke treatment algorithm. Results from the Borgess Medical Center Acute Ischemic Stroke Registry , 2012, Journal of NeuroInterventional Surgery.

[13]  Jeffrey L Saver,et al.  The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis , 2007, Stroke.

[14]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[15]  D. Liebeskind,et al.  Impact of Collateral Status on Successful Revascularization in Endovascular Treatment: A Systematic Review and Meta-Analysis , 2015, Cerebrovascular Diseases.

[16]  Christopher S Coffey,et al.  2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.

[17]  R. Higashida,et al.  Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. 2003. , 2003, Journal of vascular and interventional radiology : JVIR.

[18]  Peter Dalgaard,et al.  R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .

[19]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[20]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[21]  T. Kass-Hout,et al.  Longer procedural times are independently associated with symptomatic intracranial hemorrhage in patients with large vessel occlusion stroke undergoing thrombectomy , 2016, Journal of NeuroInterventional Surgery.

[22]  M. Mokin,et al.  Intracerebral hemorrhage secondary to intravenous and endovascular intraarterial revascularization therapies in acute ischemic stroke: an update on risk factors, predictors, and management. , 2012, Neurosurgical focus.

[23]  Vivek Nambiar,et al.  Not All “Successful” Angiographic Reperfusion Patients Are an Equal Validation of a Modified TICI Scoring System , 2014, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences.

[24]  Z. Chaudhry,et al.  Refining Angiographic Biomarkers of Revascularization: Improving Outcome Prediction After Intra-arterial Therapy , 2013, Stroke.

[25]  R. Higashida,et al.  Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke , 2003, Stroke.

[26]  William D Freeman,et al.  Validation of frontal near-infrared spectroscopy as noninvasive bedside monitoring for regional cerebral blood flow in brain-injured patients. , 2012, Neurosurgical focus.

[27]  G. Walker,et al.  Predictors of poor outcome despite recanalization: a multiple regression analysis of the NASA registry , 2015, Journal of NeuroInterventional Surgery.

[28]  Joanna M. Wardlaw,et al.  Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke: A Consensus Statement , 2013, Stroke.

[29]  F. Sharp,et al.  Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  Michael D Hill,et al.  Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. , 2013, The New England journal of medicine.

[31]  H. Lutsep,et al.  Higher Degrees of Recanalization after Mechanical Thrombectomy for Acute Stroke Are Associated with Improved Outcome and Decreased Mortality: Pooled Analysis of the MERCI and Multi MERCI Trials , 2011, American Journal of Neuroradiology.